Biggest News Aggregation in the World
📰 Beam News

Page 125 - Beam News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beam. Real-time updates on events, politics, business and more.

Beam Therapeutics Inc. (NASDAQ:BEAM) Short Interest Update

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 14,350,000 shares, an increase of 6.2% from the September 15th total of 13,510,000 shares. Based on an average daily trading volume, of 872,300 shares, the short-interest […]
United States Giuseppe Ciaramella Temasek Holdings Private Ltd Virtu Financial Cantor Fitzgerald Baillie Gifford Co

Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 8.2%

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares were down 8.2% during mid-day trading on Thursday . The company traded as low as $19.00 and last traded at $19.10. Approximately 197,048 shares traded hands during trading, a decline of 77% from the average daily volume of 869,583 shares. The stock had previously closed at […]
United States Giuseppe Ciaramella Temasek Holdings Private Ltd Credit Suisse Group Cantor Fitzgerald Beam Therapeutics Inc

Baillie Gifford & Co. Boosts Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)

Baillie Gifford & Co. boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 15.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 523,733 shares of the company’s stock after buying an additional 70,972 shares […]
United States Giuseppe Ciaramella Us Bancorp Exchange Commission Hightower Advisors Metlife Investment Management
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Beam Therapeutics (NASDAQ:BEAM) Hits New 12-Month Low at $20.81

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $20.81 and last traded at $21.26, with a volume of 141090 shares traded. The stock had previously closed at $21.43. Analysts Set New Price Targets BEAM has been […]
United States Giuseppe Ciaramella Credit Suisse Group Cantor Fitzgerald Financial Management Inc Beam Therapeutics Inc
Source: wkrb13.com

Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 4.2%

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) dropped 4.2% during trading on Monday . The company traded as low as $23.05 and last traded at $23.05. Approximately 71,600 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 870,308 shares. The stock had previously closed at […]
United States Giuseppe Ciaramella Barclays Plc Credit Suisse Group Cantor Fitzgerald Securities Exchange Commission

Comparing Biogen (NASDAQ:BIIB) & Beam Therapeutics (NASDAQ:BEAM)

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) and Biogen (NASDAQ:BIIB – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Beam Therapeutics and […]
United States United Kingdom Alkermes Pharma Ireland Sana Biotechnology Inc Pfizer Inc Biogen Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science